There is a prevalence of ileocecal involvement (IC) in women with deep, infiltrating endometriosis (DIE) according to the study presented at AAGL.
There is a prevalence of ileocecal involvement (IC) in women with deep, infiltrating endometriosis (DIE) according to the study “Ileocecal Involvement is Associated with Increased Severity of Low Rectal Endometriosis,” presented 41st Global Congress of the American Association of Gynecologic Laparoscopists. Charles Charpon, MD, of Universite Paris Descartes presented a prospective, observational study that determined the prevalence of IC and evaluated the correlation between IC and the severity of low-rectal endometriosis.
The study included 244 (74 IC+, 170 IC-) patients with diagnosed low-rectal endometriosis who had complete surgical removal of lesions. Seventy-four of the 244 women had ileocecal involvement.
While there were no significant differences in the level of surgical complications and transfusion between groups of women, the IC+ group (n=74) had more advanced endometriosis (month) (63.3 vs. 52.2; p=0.05) than the IC- group (n=170), with a higher quantity of lesions, deeper lesions (p less than 0.05), and an additional sigmoid lesion (p less than 0.01). The IC+ group was also older (34.2 vs.32.5; p less than 0.05), had more previous surgeries (less than 0.05) and had a more severe rAFS score (p less than 0.001).
A multivariate analysis indicated an association between IC and DIE as evidenced by:
• A longer duration of symptoms (greater than 5 years; odds ratio=2.2; 95% Confidence Interval: 1.2-4.0))
• An association with endometrioma (OR=2.0;95%CI: 1.1-3.6)
• More lesions and a more severe rAFS score
• A greater prevalence of sigmoid lesions(OR-2.6;95%CI: 1.4-4.7).
Chapron recommends that practitioners perform an appropriate work up in order to pre- or per-operatively diagnose ileocecal involvement.
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
Study: Pelvic floor dilator reduces pelvic floor muscle injury during vaginal delivery
August 6th 2024A new pilot study published in the International Urogynecology Journal found that Materna Medical’s Prep Device, a pelvic floor dilator, reduced full levator ani muscle avulsion during vaginal delivery in first-time mothers.
Read More
Similar success rates for synthetic and nonsynthetic slings in SUI treatment
July 31st 2024A study found that both synthetic and nonsynthetic slings show similar success rates for treating stress urinary incontinence in women, with synthetic slings demonstrating improved operative outcomes and reduced complications.
Read More
First hysterectomy using miniaturized MIRA Surgical System performed
July 30th 2024Virtual Incision Corporation has announced the successful performance of the first benign hysterectomy using their miniaturized robotic-assisted surgery device, MIRA, in a clinical trial assessing its safety and efficacy.
Read More